PT  - JOURNAL ARTICLE
AU  - María Gabriela Palacios-Verdú
AU  - Maria Segura-Puimedon
AU  - Cristina Borralleras
AU  - Raquel Flores
AU  - Miguel Del Campo
AU  - Victoria Campuzano
AU  - Luis Alberto Pérez-Jurado
TI  - Metabolic abnormalities in Williams–Beuren syndrome
AID  - 10.1136/jmedgenet-2014-102713
DP  - 2015 Apr 01
TA  - Journal of Medical Genetics
PG  - 248--255
VI  - 52
IP  - 4
4099  - http://jmg.bmj.com/content/52/4/248.short
4100  - http://jmg.bmj.com/content/52/4/248.full
SO  - J Med Genet2015 Apr 01; 52
AB  - Background Williams–Beuren syndrome (WBS, OMIM-194050) is a neurodevelopmental disorder with multisystemic manifestations caused by a 1.55–1.83 Mb deletion at 7q11.23 including 26–28 genes. Reported endocrine and metabolic abnormalities include transient hypercalcaemia of infancy, subclinical hypothyroidism in ∼30% of children and impaired glucose tolerance in ∼75% of adult individuals. The purpose of this study was to further study metabolic alterations in patients with WBS, as well as in several mouse models, to establish potential candidate genes. Methods We analysed several metabolic parameters in a cohort of 154 individuals with WBS (data available from 69 to 151 cases per parameter), as well as in several mouse models with complete and partial deletions of the orthologous WBS locus, and searched for causative genes and potential modifiers. Results Triglyceride plasma levels were significantly decreased in individuals with WBS while cholesterol levels were slightly decreased compared with controls. Hyperbilirubinemia, mostly unconjugated, was found in 18.3% of WBS cases and correlated with subclinical hypothyroidism and hypotriglyceridemia, suggesting common pathogenic mechanisms. Haploinsufficiency at MLXIPL and increased penetrance for hypomorphic alleles at the UGT1A1 gene promoter might underlie the lipid and bilirubin alterations. Other disturbances included increased protein and iron levels, as well as the known subclinical hypothyroidism and glucose intolerance. Conclusions Our results show that several unreported biochemical alterations, related to haploinsufficiency for specific genes at 7q11.23, are relatively common in WBS. The early diagnosis, follow-up and management of these metabolic disturbances could prevent long-term complications in this disorder.